首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

市場調查報告書

商品編碼

1559476

透視檢查裝置 - 市場考察，競爭情形，市場預測(2030年)

Fluoroscopy Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年09月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球透視設備市場規模為53億美元，預計2030年將達到73億美元，預計在2024-2030年預測期內複合年增長率為4.74%。對透視設備的需求主要是由於冠狀動脈疾病（CAD）和慢性阻塞性肺病（COPD）等慢性疾病在全球範圍內的患病率不斷上升、產品上市的增加以及對疾病早期檢測的認識不斷增強而推動的。

透視設備的機械原理

根據《世界心臟報告（2023）》最新數據，到 2021 年，全球將有超過 5 億人患有心血管疾病。

根據英國心臟基金會的全球心臟和循環系統疾病情況說明書（2024 年），全球約有 2 億人患有 CAD。因此，隨著心血管疾病患者數量的增加，對透視設備等先進診斷選擇的需求也增加。它們在多種心血管疾病的診斷和治療中發揮重要作用。

根據世界衛生組織（2024）提供的數據，2019年有2.62億人患有氣喘。此外，到2023年，全球將有3.92億慢性阻塞性肺病患者，其中四分之三生活在低收入和中等收入國家。呼吸系統疾病經常引起氣喘和慢性阻塞性肺病等併發症，增加了先進診斷和治療的需求。因此，呼吸系統疾病的日益流行直接促進了螢光透視設備市場的擴張。

此外，全球螢光檢查設備產品的增加也預計將推動整體市場的成長。例如，2024 年 1 月，Carestream Health, Inc. 推出了名為 DXR-Excel Plus 的 X 光系統。 DXR-Excel 是一款適用於透視檢查和一般 X 光檢查的二合一系統，可為各種檢查提供即時影像。

因此，鑑於與各種慢性疾病相關的大量患者群體以及全球不斷增加的產品推出，預計透視設備市場在 2024 年至 2030 年的預測期內將顯著增長。

然而，長期或反覆接觸電離輻射等因素會對患者和醫護人員造成風險，而其他替代設備的可用性限制了螢光檢查設備的發展，這可能是主要的抑制因素。

透視設備細分分析

在螢光檢查設備產品類型領域，預計行動 C 型臂系統類別將在 2023 年佔據螢光檢查設備市場的重要收入佔有率。移動式 C 型臂系統的移動性和靈活性使其廣受歡迎，尤其是在進行門診手術的診所、急診室和手術室中。近年來，由於能夠產生高品質影像的技術進步，對可移動 C 形臂的需求逐漸增加。此外，經常需要移動 C 形臂成像引導的微創治療的不斷增長趨勢也有助於市場佔有率的成長。

此外，該類別產品的推出預計也將推動行動 C 臂類別的市場成長。例如，2022 年 7 月，富士軟片控股公司宣佈在美國推出 FDR Cross，這是一款專為醫院和門診手術中心 (ASC) 打造的創新混合 C 形臂和移動 X 光解決方案。這款雙功能 C 型臂是首款在單一平台上提供行動透視和放射線攝影的產品。

此外，移動 C 形臂透視設備是現代醫學影像中極其通用和必不可少的工具，特別是在手術和介入放射學中。它擁有使用數位平板偵測器的先進影像處理能力，可在低劑量下實現出色的影像品質。它還具有用戶友好的觸控螢幕和直觀的介面，使醫療保健專業人員可以輕鬆使用。一些模型還包括 3D 成像和導航系統，這對於複雜的手術至關重要。

因此，行動 C 型臂螢光檢查設備類別提供的各種優勢和應用將有助於該細分市場的成長，並推動預測期內整體螢光檢查設備市場的成長。

本報告針對全球透視設備市場進行研究和分析，提供各地區的市場規模和預測、過去三年的產品/技術發展以及各細分市場的業績和前景等資訊。

Siemens Healthcare Private Limited
GE HealthCare
Koninklijke Philips N.V
Shimadzu Corporation
Ziehm Imaging GmbH
Carestream Health, Inc.
Orthoscan, Inc.
CANON MEDICAL SYSTEMS CORPORATION
FUJIFILM Holdings Corporation
Allengers
DMS Group
Villa Sistemi Medicali Spa
Eurocolumbus srl
Genoray Co., Ltd.
Bimedis
Omega Medical Imaging, LLC
Hologic, Inc
Adani Systems Inc.
Agfa-Gevaert Group
Scanray Technologies Limited

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明，諮詢方式

簡介目錄圖表

Product Code: DIMDCL0759

Fluoroscopy Equipment By Product Type (Fixed C-Arm Systems And Mobile C-Arm Systems), Application (Cardiology, Respiratory, Oncology, And Others), End-User (Hospitals And Clinics, Diagnostic Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic diseases globally, increase in product launches, and increasing awareness about early disease detection

The fluoroscopy equipment device market was valued at USD 5.30 billion in 2023, growing at a CAGR of 4.74% during the forecast period from 2024 to 2030 to reach USD 7.30 billion by 2030. The demand for fluoroscopy equipment is primarily being boosted by the rising prevalence of chronic diseases such as Coronary Artery Disease (CAD), Chronic Obstructive Pulmonary Disease (COPD), among others globally, increase in product launches, and rising awareness about early disease detection are some factors contributing to the positive growth of the fluoroscopy equipment market during the forecast period from 2024 to 2030.

Fluoroscopy Equipment Dynamics:

As per the recent data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people were living with CAD around the world. Therefore, with rise in the cases of cardiovascular disorders, there's a growing demand for advanced diagnostic options like fluoroscopy equipment. These play a crucial role in the diagnosis and treatment of various cardiovascular conditions.

According to the data provided by WHO (2024), in 2019 that there were 262 million people affected by asthma. Additionally in 2023, there were 392 million people living with COPD globally, with three quarters of them living in low and middle income countries. As, respiratory diseases often lead to complications such as asthma and COPD, it spurs the critical need for advanced diagnostic and treatment options. Therefore, the growing incidence of respiratory diseases directly contributes to the expanding market for fluoroscopy equipment.

Moreover, the increased number of product launches in the fluoroscopy equipment globally is also expected to boost the overall market growth. For instance, in January 2024, Carestream Health, Inc. launched an X-ray system called DXR-Excel Plus. It is a two-in-one system for both fluoroscopy and general radiology that delivers real-time, images for a wide range of examinations.

Therefore, considering the large patient pool associated with different chronic disorders, and the rising product launches globally, the market for fluoroscopy equipment is expected to grow significantly during the given forecast period from 2024 to 2030.

However, prolonged or repeated exposure to ionizing radiations that raise risks for patients as well as for healthcare professionals, availability of other alternative equipments, among others are some of the key constraints that may limit the growth of the fluoroscopy equipment.

Fluoroscopy Equipment Segment Analysis:

Fluoroscopy Equipment by Product type (Fixed C-Arm Systems and Mobile C-Arm Systems), Application (Cardiology, Respiratory, Oncology, and Others), End-User (Hospitals and Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest Of The World)

In the product type segment of the fluoroscopy equipment, the mobile C-arm system category was estimated to amass a significant revenue share in the fluoroscopy equipment market in 2023. Portability and flexibility of mobile C-arm systems have become more common, particularly in ambulatory surgical clinics, emergency rooms, and operating rooms. The need for mobile C-arms has been rising gradually in recent years as a result of technological improvements that enabled them to produce high-quality images. Their increasing market share has also been aided by the growing trend towards minimally invasive treatments, which frequently need mobile C-arm imaging guidance.

Additionally, product launches in this category are also expected to drive the market growth for the mobile c-arms category. For example, In July 2022, FUJIFILM Holdings Corporation announced US launch of the FDR Cross, an innovative hybrid c-arm and portable x-ray solution built for hospitals and ambulatory surgery centers (ASC). The dual-function c-arm was the first of its kind to offer portable fluoroscopic and radiographic imaging on a single platform.

Moreover, Mobile C-arm fluoroscope equipment is a highly versatile and essential tool in contemporary medical imaging, particularly in surgery and interventional radiology. They boast advanced imaging capabilities with digital flat-panel detectors that deliver superior image quality with lower radiation doses. They also feature user-friendly touch screens and intuitive interfaces, making them accessible to medical professionals. Some models include 3D imaging and navigation systems, which are crucial for complex procedures.

Therefore, the various advantages and applications provided by the mobile C arm fluoroscopy equipment category will contribute to the growth of the segment, thereby driving the growth of the overall fluoroscopy equipment market during the forecast period.

North America Is Expected To Dominate The Overall Fluoroscopy Equipment:

North America is expected to account for the highest proportion of the fluoroscopy equipment market in 2023, out of all regions due to several key factors. The high incidence of chronic diseases, including cardiovascular conditions and respiratory illnesses, increases the demand for accurate diagnostic and treatment tools. Additionally, the efficient regulatory frameworks that ensure the safety and efficacy of medical devices further encourage the adoption of fluoroscopy equipment in clinical settings, also the increased product launches in the US. Together, these factors drive the expansion of the fluoroscopy equipment market in North America.

According to the latest updated data provided by the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US had a heart attack every year, and about 1 out of 5 are silent heart attacks.

Additionally, the latest data provided by the National Institute of Health (2023), stated that 20.5 million people in the US were living with CAD. Fluoroscopy is vital for visualizing the heart and blood vessels in real-time, identifying blockages, abnormalities, and reduced blood flow for early intervention. It guides procedures like angioplasty and stent placement with precision, ensuring optimal outcomes in managing heart conditions. Therefore, the high incidence of heart attacks and the widespread prevalence of coronary artery disease may siginificantly increase the demand for fluoroscopy equipment during the forecast period.

According to the latest updated data by the American Lung Association, in 2023 approximately 11.7 million people in the US were living with chronic respiratory disorders, which over time made it harder for patients to breathe.

Furthermore, as per the data provided by CDC (2023), in 2021, approximately 14.2 million people in the US had chronic obstructive pulmonary disease (COPD). Fluoroscopy's real-time imaging helps identify respiratory system issues like blockages. During procedures like bronchoscopy, it guides physicians to navigate airways precisely, visualize problem areas, and collect diagnostic samples.

Thus the increase in various respiratory disorders requires precise diagnosis and treatment, the importance of fluoroscopy equipment in respiratory care is increasingly recognized, thus driving the demand for fluoroscopy equipment.

Furthermore, increased product launches in North America also plays a major role in the increasing market for fluoroscopy equipment. For instance, in June 2021, FUJIFILM Holdings Corporation, Inc., announced the launch of Persona RF PREMIUM's in the US market. The Persona RF PREMIUM is a unique radiography and fluoroscopy system that offered real-time imaging for the skeletal, digestive, urinary, respiratory, and reproductive systems, as well as for particular organs like the kidneys, heart, and lung.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American fluoroscopy equipment market growth during the forecast period from 2024 to 2030.

Fluoroscopy Equipment Key Players:

Some of the key market players operating in the fluoroscopy equipment include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V, Shimadzu Corporation, Ziehm Imaging GmbH, Carestream Health, Inc., Orthoscan, Inc., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Allengers, DMS Group, Villa Sistemi Medicali Spa, Eurocolumbus srl, Genoray Co., Ltd., Bimedis, Omega Medical Imaging, LLC., Hologic, Inc, Adani Systems Inc, Agfa-Gevaert Group, Scanray Technologies Limited, and others.

Recent Developmental Activities In The Fluoroscopy Equipment:

In November 2023, The Norwegian Vestre Viken Health Trust and Philips announced that AI-enabled clinical care had been implemented to help radiologists improve patient care. The clinical applications platform powered by AI from Philips will expedite the diagnosis of bone fractures.
In September 2021, Siemens Healthcare Private Limited launched Luminos Impulse that offered high efficiency for digital fluoroscopy and radiography. It included seamless imaging chain, comprehensive dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Key Takeaways From The Fluoroscopy Equipment Report Study

Market size analysis for current fluoroscopy equipment size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global fluoroscopy equipment.
Various opportunities available for the other competitors in the fluoroscopy equipment space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current fluoroscopy equipment scenario?
Which are the regions and countries where companies should have concentrated on opportunities for fluoroscopy equipment growth in the coming future?

Target Audience Who Can Be Benefited From The Fluoroscopy Equipment Report Study

Fluoroscopy equipment product providers
Research organizations and consulting companies
Fluoroscopy equipment-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in fluoroscopy equipment
Various end-users who want to know more about the fluoroscopy equipment and the latest technological developments in the fluoroscopy equipment

Frequently Asked Questions For The Fluoroscopy Equipment:

1. What are fluoroscopy equipment?

Fluoroscopy equipment is a medical imaging technology that uses X-rays to produce moving, real-time images of a patient's interior tissues. It is made up of an X-ray source, a display monitor, a collimator, and a fluorescent screen or image intensifier.

2. What is the market for fluoroscopy equipment?

The fluoroscopy equipment device market was valued at USD 5.30 billion in 2023, growing at a CAGR of 4.74% during the forecast period from 2024 to 2030 to reach USD 7.30 billion by 2030.

3. What are the drivers for the fluoroscopy equipment?

The fluoroscopy equipment is slated to witness prosperity owing to factors such as the rising prevalence of chronic diseases such as Coronary Artery Disease (CAD) and Chronic Obstructive Pulmonary Disease (COPD) globally, an increase in product launches, and the rising awareness about early disease detection, among others thus contributing to the positive growth of the fluoroscopy equipment market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the fluoroscopy equipment?

5. Which region has the highest share in the fluoroscopy equipment?

North America is expected to dominate the overall Fluoroscopy Equipment during the forecast period from 2024 to 2030. This is owing to the high incidence of chronic diseases, including cardiovascular conditions and respiratory illnesses, increasing the demand for accurate diagnostic and treatment tools. Additionally, the efficient regulatory frameworks that ensure the safety and efficacy of medical devices, and the increased product launches further encourage the adoption of fluoroscopy equipment in clinical settings in the US. Together, these factors are expected to drive the expansion of the fluoroscopy equipment market in North America.

1. Fluoroscopy Equipment Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Fluoroscopy Equipment Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Fluoroscopy Equipment Market Key Factors Analysis

5.1. Fluoroscopy Equipment Market Drivers
- 5.1.1. The rising prevalence of chronic diseases globally
- 5.1.2. Increase in product launches
- 5.1.3. Increasing awareness about early disease detection
5.2. Fluoroscopy Equipment Market Restraints and Challenges
- 5.2.1. Prolonged or repeated exposure to ionizing radiation that raises risks for patients and healthcare professionals
5.3. Fluoroscopy Equipment Market Opportunities
- 5.3.1. Integration with AI to facilitate procedure optimization

6. Fluoroscopy Equipment Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Fluoroscopy Equipment Market Assessment

7.1. By Product Type
- 7.1.1. Fixed C-Arm Systems
- 7.1.2. Mobile C-Arm Systems
7.2. By Application
- 7.2.1. Cardiology
- 7.2.2. Respiratory
- 7.2.3. Oncology
- 7.2.4. Others
7.3. By End-User
- 7.3.1. Hospitals and Clinics
- 7.3.2. Diagnostic Centers
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.1.2. Canada Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.1.3. Mexico Fluoroscopy Equipment Size in USD million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.2.2. Germany Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.2.3. United Kingdom Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.2.4. Italy Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.2.5. Spain Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.2.6. Rest of Europe Fluoroscopy Equipment Size in USD million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.3.2. Japan Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.3.3. India Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.3.4. Australia Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.3.5. South Korea Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.3.6. Rest of Asia-Pacific Fluoroscopy Equipment Size in USD million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.4.2. Africa Fluoroscopy Equipment Size in USD million (2021-2030)
  - 7.4.4.3. South America Fluoroscopy Equipment Size in USD million (2021-2030)

8. Fluoroscopy Equipment Market Company and Product Profiles

8.1. Siemens Healthcare Private Limited
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. GE HealthCare
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Koninklijke Philips N.V
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Shimadzu Corporation
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Ziehm Imaging GmbH
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Carestream Health, Inc.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Orthoscan, Inc.
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. CANON MEDICAL SYSTEMS CORPORATION
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. FUJIFILM Holdings Corporation
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Allengers
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. DMS Group
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Villa Sistemi Medicali Spa
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Eurocolumbus srl
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Genoray Co., Ltd.
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Bimedis
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Omega Medical Imaging, LLC
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Hologic, Inc
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Adani Systems Inc.
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Agfa-Gevaert Group
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. Scanray Technologies Limited
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy